Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults without any pre existing liver disease. Hyperammonemic encephalopathy (HAE) is a serious paraneoplastic syndrome, and several cases of HAE have been reported in patients with FLHCC. This condition is rare; hence, there are currently no management guidelines for cancer-related HAE. Herein, we report a case of an 18-year-old man with advanced FLHCC who developed HAE during the first course of chemotherapy consisting of cisplatin, doxorubicin, 5-fluorouracil, and interferon-α. He was successfully treated with continuous venovenous hemofiltration, sodium benzoate, sodium phenylbutyrate, and amino acid supplementation for HAE. After the second course of chemotherapy, he underwent surgery, and thereafter, his ammonia levels were normal without any ammonia scavenger therapy. Treatments for HAE described here will be helpful for this rare, but serious metabolic complication of FLHCC and could partially applied to HAE related to any malignancies.
Citations
Citations to this article as recorded by
Mitochondrial targets in hyperammonemia: Addressing urea cycle function to improve drug therapies Marco F. Moedas, Ricardo J.M. Simões, Margarida F.B. Silva Biochemical Pharmacology.2024; 222: 116034. CrossRef
Fibroadenoma Intracanalicular Hipercelular: uma revisão de literatura e relato de 5 casos Isadora Benevides Silva Gondim Nascimento, Roberta Pereira Guerra Pedra, Amanda Veloso Teixeira, Maria Isabel Teles Nogueira, Kaio Henrique Oliveira Pontes Journal Archives of Health.2024; 5(3): e1860. CrossRef
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma Solomon N. Levin, Michael D. Tomasini, James Knox, Mahsa Shirani, Bassem Shebl, David Requena, Jackson Clark, Søren Heissel, Hanan Alwaseem, Rodrigo Surjan, Ron Lahasky, Henrik Molina, Michael S. Torbenson, Barbara Lyons, Rachael D. Migler, Philip Coffino Science Advances.2023;[Epub] CrossRef
WITHDRAWN: Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review Arwa Ahmed, Fateen Ata, Mohammed Gaber, Mahir Petkar, Ahmed Mahfouz, Peter Schirmacher, Sara Musa, Ahmed Hashim Current Problems in Cancer: Case Reports.2022; : 100141. CrossRef
Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review Arwa Ahmed, Fateen Ata, Mohammed Gaber, Mahir Petkar, Ahmed Mahfouz, Peter Schirmacher, Sara Musa, Ahmed Hashim Current Problems in Cancer.2022; 46(3): 100847. CrossRef
Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias Teodoro Jerves, Nenad Blau, Carlos R. Ferreira Molecular Genetics and Metabolism.2022; 136(2): 118. CrossRef
Paraneoplastic syndromes in hepatocellular carcinoma: a review Yuki Ong, Cheong Wei Terence Huey, Vishalkumar Girishchandra Shelat Expert Review of Gastroenterology & Hepatology.2022; 16(5): 449. CrossRef
Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment Kena Song, Zhangqing Yu, Xiangyang Zu, Guoqiang Li, Zhigang Hu, Yun Xue International Journal of Molecular Sciences.2022; 23(18): 10509. CrossRef
Fibrolamellar carcinoma: An entity all its own Allison F. O'Neill, Alanna J. Church, Antonio R. Perez-Atayde, Raja Shaikh, Karen J. Marcus, Khashayar Vakili Current Problems in Cancer.2021; 45(4): 100770. CrossRef
Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature Jia-Lei Chen, Xi Yu, Rong Luo, Ming Liu World Journal of Clinical Cases.2021; 9(36): 11457. CrossRef